Smither John W

CIK 00015595839 companiesNAARDEN, P7

SEC Profile

Transactions

Companies

Filings

CIK

0001559583

Recent Transactions

50 trades

Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2026-01-07+15,300→ 15,300 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-07+3,400→ 10,360 total
Award
GENELUX Corp$GNLX
Common Stock
2025-08-27+22,283→ 74,994 total
Award
GENELUX Corp$GNLX
Stock Option (Right to Buy)
2025-08-27+28,576→ 28,576 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-07+6,960→ 6,960 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-01-06+32,500→ 32,500 total
Award
GENELUX Corp$GNLX
Stock Option Right to Buy)
2024-08-01+50,469→ 50,469 total
Award
GENELUX Corp$GNLX
Stock Option Right to Buy)
2024-08-01+50,469→ 50,469 total
Award
GENELUX Corp$GNLX
Common Stock
2024-08-01+39,541→ 52,711 total
Purchase
GENELUX Corp$GNLX
Common Stock
2024-05-29+6,250→ 13,170 total
Purchase
GENELUX Corp$GNLX
Common Stock Warrant (Right to Buy)
2024-05-29+6,250→ 6,250 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2024-02-13+8,572→ 11,365 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2024-02-13+2,793→ 2,793 total
Disposition to Issuer
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (right to buy)
2024-02-13−25,718→ 0 total
Disposition to Issuer
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (right to buy)
2024-02-13−8,379→ 0 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2024-01-01+10,000→ 10,000 total
Disposition to Issuer
Applied Molecular Transport Inc.
Stock Option (Right to Buy)
2023-12-27−20,000→ 0 total
Disposition to Issuer
Applied Molecular Transport Inc.
Stock Option (Right to Buy)
2023-12-27−60,000→ 0 total
Sale
GENELUX Corp$GNLX
Common Stock
2023-09-13$20.78/sh−900→ 6,920 total
Award
GENELUX Corp$GNLX
Stock Option (Right to Buy)
2023-09-11+8,447→ 8,447 total
Award
GENELUX Corp$GNLX
Common Stock
2023-09-11+6,920→ 7,820 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (right to buy)
2023-08-31+125,000→ 125,000 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2023-06-22+20,000→ 20,000 total
Award
Applied Molecular Transport Inc.
Stock Option (Right to Buy)
2023-06-14+20,000→ 20,000 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2023-01-20+36,875→ 36,875 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-09+20,000→ 20,000 total
Award
Applied Molecular Transport Inc.
Stock Option (Right to Buy)
2022-05-24+20,000→ 20,000 total
Disposition to Issuer
Applied Molecular Transport Inc.
Stock Option (Right to Buy)
2022-05-24−20,000→ 0 total
Award
Applied Molecular Transport Inc.
Stock Option (Right to Buy)
2022-01-27+60,000→ 60,000 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2021-10-06+40,000→ 40,000 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2021-08-25+24,142→ 24,142 total
Award
eFFECTOR Therapeutics, Inc.
Earn-out Right
2021-08-25+3,556→ 3,556 total
Award
eFFECTOR Therapeutics, Inc.
Common Stock
2021-08-25+24,142→ 24,142 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-03-10$32.90/sh−500→ 46,321 total
Exercise/Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2021-03-10−500→ 44,982 total
Exercise/Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-03-10$1.68/sh+500→ 46,821 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-03-10$32.90/sh−1,250→ 86,715 total
Exercise/Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-03-04$1.68/sh+12,396→ 46,321 total
Exercise/Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2021-03-04−12,396→ 97,684 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2021-03-03+28,800→ 28,800 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-03-03+9,500→ 33,925 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-03-01$34.20/sh−773→ 24,425 total
Exercise/Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2021-02-10−750→ 45,482 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-02-10$35.64/sh−2,000→ 87,965 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-02-10$35.64/sh−750→ 25,198 total
Exercise/Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-02-10$1.68/sh+750→ 25,948 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-02-01$35.00/sh−3,750→ 89,965 total
Exercise/Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-02-01$1.68/sh+1,250→ 26,448 total
Exercise/Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2021-02-01−1,250→ 46,232 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-02-01$35.00/sh−1,250→ 25,198 total

Smither John W

Recent Transactions

Companies

Recent Filings

Address